Asia: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in Asia

The Asian medicaments containing corticosteroid hormones market shrank slightly to $X in 2022, which is down by X% against the previous year. Over the period under review, consumption recorded a pronounced decline. Over the period under review, the market hit record highs at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Corticosteroid Hormones in Asia

In value terms, medicaments containing corticosteroid hormones production dropped to $X in 2022 estimated in export price. Overall, production saw a abrupt curtailment. The most prominent rate of growth was recorded in 2015 when the production volume increased by X%. The level of production peaked at $X in 2012; however, from 2013 to 2022, production remained at a lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Exports of Medicaments Containing Corticosteroid Hormones

Exports in Asia

In 2022, overseas shipments of medicaments containing corticosteroid hormones increased by X% to X tons, rising for the sixth year in a row after two years of decline. Over the period under review, exports recorded strong growth. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. The volume of export peaked in 2022 and is expected to retain growth in years to come.

In value terms, medicaments containing corticosteroid hormones exports skyrocketed to $X in 2022. Total exports indicated pronounced growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2014 when exports increased by X%. The level of export peaked in 2022 and is likely to see gradual growth in the near future.

Exports by Country

India (X tons) and Pakistan (X tons) represented roughly X% of total exports in 2022. It was distantly followed by China (X tons), achieving an X% share of total exports. Indonesia (X tons), Turkey (X tons) and the United Arab Emirates (X tons) held a relatively small share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Pakistan (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, China ($X) emerged as the largest medicaments containing corticosteroid hormones supplier in Asia, comprising X% of total exports. The second position in the ranking was held by India ($X), with a X% share of total exports. It was followed by Pakistan, with a X% share.

From 2012 to 2022, the average annual growth rate of value in China totaled X%. The remaining exporting countries recorded the following average annual rates of exports growth: India (X% per year) and Pakistan (X% per year).

Export Prices by Country

The export price in Asia stood at $X per ton in 2022, picking up by X% against the previous year. In general, the export price, however, recorded a abrupt slump. The pace of growth was the most pronounced in 2014 when the export price increased by X%. The level of export peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while Pakistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in Asia

In 2022, approx. X tons of medicaments containing corticosteroid hormones were imported in Asia; with an increase of X% against the previous year. Total imports indicated prominent growth from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2013 indices. The pace of growth appeared the most rapid in 2016 with an increase of X%. The volume of import peaked in 2022 and is expected to retain growth in years to come.

In value terms, medicaments containing corticosteroid hormones imports totaled $X in 2022. Total imports indicated a buoyant increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2013 indices. The growth pace was the most rapid in 2018 when imports increased by X% against the previous year. Over the period under review, imports reached the maximum in 2022 and are expected to retain growth in years to come.

Imports by Country

In 2022, China (X tons), distantly followed by Japan (X tons), the United Arab Emirates (X tons) and Malaysia (X tons) represented the key importers of medicaments containing corticosteroid hormones, together creating X% of total imports. The following importers - Saudi Arabia (X tons), Turkey (X tons), South Korea (X tons), Uzbekistan (X tons), Thailand (X tons), Kazakhstan (X tons), Vietnam (X tons), the Philippines (X tons) and Iraq (X tons) - together made up X% of total imports.

Imports into China increased at an average annual rate of X% from 2012 to 2022. At the same time, Malaysia (X%), Uzbekistan (X%), the United Arab Emirates (X%), Vietnam (X%), the Philippines (X%), Kazakhstan (X%), Iraq (X%), South Korea (X%), Thailand (X%), Japan (X%) and Turkey (X%) displayed positive paces of growth. Moreover, Malaysia emerged as the fastest-growing importer imported in Asia, with a CAGR of X% from 2012-2022. By contrast, Saudi Arabia (X%) illustrated a downward trend over the same period. The United Arab Emirates (X p.p.), China (X p.p.), Malaysia (X p.p.) and Uzbekistan (X p.p.) significantly strengthened its position in terms of the total imports, while Turkey, Japan and Saudi Arabia saw its share reduced by X%, X% and X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest medicaments containing corticosteroid hormones importing markets in Asia were China ($X), Japan ($X) and South Korea ($X), together comprising X% of total imports. The United Arab Emirates, Turkey, Vietnam, Saudi Arabia, Thailand, Kazakhstan, the Philippines, Malaysia, Iraq and Uzbekistan lagged somewhat behind, together accounting for a further X%.

Malaysia, with a CAGR of X%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in Asia amounted to $X per ton, shrinking by X% against the previous year. Over the period under review, the import price showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2017 when the import price increased by X% against the previous year. The level of import peaked at $X per ton in 2014; however, from 2015 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Japan ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Thailand (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :